Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Goodwill & Intangibles: 2011-2022

Historic Goodwill & Intangibles for Abeona Therapeutics (ABEO) over the last 10 years, with Sep 2022 value amounting to $2.2 million.

  • Abeona Therapeutics' Goodwill & Intangibles fell 93.77% to $2.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.2 million, marking a year-over-year decrease of 93.77%. This contributed to the annual value of $2.2 million for FY2021, which is 93.78% down from last year.
  • Per Abeona Therapeutics' latest filing, its Goodwill & Intangibles stood at $2.2 million for Q3 2022, which was down 0.00% from $2.2 million recorded in Q2 2022.
  • Over the past 5 years, Abeona Therapeutics' Goodwill & Intangibles peaked at $77.3 million during Q4 2018, and registered a low of $2.2 million during Q4 2021.
  • Its 3-year average for Goodwill & Intangibles is $22.9 million, with a median of $34.6 million in 2021.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first skyrocketed by 112.18% in 2018, then tumbled by 93.78% in 2021.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' Goodwill & Intangibles stood at $77.3 million in 2018, then skyrocketed by 107.48% to $75.1 million in 2019, then tumbled by 53.28% to $34.7 million in 2020, then crashed by 93.78% to $2.2 million in 2021, then slumped by 93.77% to $2.2 million in 2022.
  • Its last three reported values are $2.2 million in Q3 2022, $2.2 million for Q2 2022, and $2.2 million during Q1 2022.